The Scientific and Research Team at Xencor focuses on the discovery, development, and translational research of monoclonal antibody therapeutics. They employ a multidisciplinary approach, leveraging expertise in biology, pharmacology, and statistical programming to advance treatments for autoimmune disorders, asthma, allergic diseases, and cancer. The team collaborates across various functions, ensuring the innovation and efficacy of new therapeutic candidates from discovery through clinical development.